Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Influenza

  Free Subscription


28.11.2022

1 Am J Med
8 Antiviral Res
9 BMJ
1 Cell
2 Epidemiol Infect
1 J Gen Virol
1 J Immunol
1 J Infect
1 J Infect Dis
4 J Virol
1 JAMA
2 Lancet
4 MMWR Morb Mortal Wkly Rep
6 N Engl J Med
2 Pediatrics
2 PLoS Med
59 PLoS One
3 Proc Natl Acad Sci U S A
20 Vaccine
1 Virology
1 Virus Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. BAKSHI CS, Centone AJ, Wormser GP
    SARS-CoV-2 is Emerging in White-Tailed Deer and Can Infect and Spread Among Deer Mice Experimentally: What About Deer Ticks?
    Am J Med. 2022;135:1395-1396.
    PubMed        


    Antiviral Res

  2. SHANG W, Dai W, Yao C, Xu L, et al
    In vitro and in vivo evaluation of the main protease inhibitor FB2001 against SARS-CoV-2.
    Antiviral Res. 2022;208:105450.
    PubMed         Abstract available

  3. VARRICCHIO C, Mathez G, Pillonel T, Bertelli C, et al
    Geneticin shows selective antiviral activity against SARS-CoV-2 by interfering with programmed -1 ribosomal frameshifting.
    Antiviral Res. 2022;208:105452.
    PubMed         Abstract available

  4. FABREGA-FERRER M, Herrera-Morande A, Muriel-Goni S, Perez-Saavedra J, et al
    Structure and inhibition of SARS-CoV-1 and SARS-CoV-2 main proteases by oral antiviral compound AG7404.
    Antiviral Res. 2022;208:105458.
    PubMed         Abstract available

  5. ZHU Y, Hu Y, Liu N, Chong H, et al
    Potent inhibition of diverse Omicron sublineages by SARS-CoV-2 fusion-inhibitory lipopeptides.
    Antiviral Res. 2022;208:105445.
    PubMed         Abstract available

  6. KIM TY, Kim JY, Kwon HC, Jeon S, et al
    Astersaponin I from Aster koraiensis is a natural viral fusion blocker that inhibit the infection of SARS-CoV-2 variants and syncytium formation.
    Antiviral Res. 2022 Oct 14:105428. doi: 10.1016/j.antiviral.2022.105428.
    PubMed         Abstract available

  7. BRAY M
    Antiviral Research: At age 41, a transition.
    Antiviral Res. 2022 Oct 14:105447. doi: 10.1016/j.antiviral.2022.105447.
    PubMed         Abstract available

  8. JEONG JH, Chokkakula S, Min SC, Kim BK, et al
    Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice.
    Antiviral Res. 2022;208:105430.
    PubMed         Abstract available

  9. ZHU Y, Binder J, Yurgelonis I, Rai D, et al
    Generation of a VeroE6 Pgp gene knock out cell line and its use in SARS-CoV-2 antiviral study.
    Antiviral Res. 2022 Oct 5:105429. doi: 10.1016/j.antiviral.2022.105429.
    PubMed         Abstract available


    BMJ

  10. ZHANG X, Barr B, Green M, Hughes D, et al
    Impact of community asymptomatic rapid antigen testing on covid-19 related hospital admissions: synthetic control study.
    BMJ. 2022;379:e071374.
    PubMed         Abstract available

  11. KNIGHT M, Engjom HM
    Investing in robust surveillance of the effects of covid-19 and future emerging infections in pregnancy should be prioritised.
    BMJ. 2022;379:o2810.
    PubMed        

  12. WANG Y, Bye J, Bales K, Gurdasani D, et al
    Understanding and neutralising covid-19 misinformation and disinformation.
    BMJ. 2022;379:e070331.
    PubMed        

  13. OXTOBY K
    Revitalising mental healthcare after covid-19.
    BMJ. 2022;379:o2122.
    PubMed        

  14. IACOBUCCI G
    Covid-19: "Grotesque inequity" that only a quarter of paxlovid courses go to poorer countries.
    BMJ. 2022;379:o2795.
    PubMed        

  15. MAHASE E
    Covid-19: Is the UK still tracking the virus-and other questions answered.
    BMJ. 2022;379:o2802.
    PubMed        

  16. VIZE R
    Rishi Sunak's covid record-and what it tells us about his views on health, wealth, and the value of science.
    BMJ. 2022;379:o2715.
    PubMed        

  17. ZHENG B, Green ACA, Tazare J, Curtis HJ, et al
    Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform.
    BMJ. 2022;379:e071932.
    PubMed         Abstract available

  18. JARDINE MJ, Kotwal SS, Bassi A, Hockham C, et al
    Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
    BMJ. 2022;379:e072175.
    PubMed         Abstract available


    Cell

  19. LE NOUEN C, Nelson CE, Liu X, Park HS, et al
    Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys.
    Cell. 2022 Nov 10:S0092-8674(22)01418-0. doi: 10.1016/j.cell.2022.
    PubMed         Abstract available


    Epidemiol Infect

  20. BEEBEEJAUN K, Pebody R, Ciobanu S, Pukkila J, et al
    UEFA Euro 2020: lessons from the first multi-city international mass gathering during the COVID-19 pandemic.
    Epidemiol Infect. 2022;150:e182.
    PubMed         Abstract available

  21. MCGRATH J, McAloon CG, More SJ, Garrett S, et al
    Risk factors for SARS-CoV-2 infection in healthcare workers following an identified nosocomial COVID-19 exposure during waves 1-3 of the pandemic in Ireland.
    Epidemiol Infect. 2022;150:e186.
    PubMed         Abstract available


    J Gen Virol

  22. DEMPSEY R, Ritter L, Parker L
    Strain development of A/H1N1pdm09 candidate vaccine viruses for the 2021-22 northern hemisphere influenza season.
    J Gen Virol. 2022;103.
    PubMed         Abstract available


    J Immunol

  23. ZHENG MZM, Fritzlar S, Wang Z, Tan TK, et al
    Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity.
    J Immunol. 2022;209:1832-1836.
    PubMed         Abstract available


    J Infect

  24. ZHOU J, Chen Y, Shao Z, Ding S, et al
    Continuing evolution and transmission of avian influenza A(H3N8) viruses is a potential threat to public health.
    J Infect. 2022 Nov 17:S0163-4453(22)00651-X. doi: 10.1016/j.jinf.2022.
    PubMed        


    J Infect Dis

  25. MONTO AS, Lauring AS, Martin ET
    SARS-CoV-2 Vaccine Strain Selection: Guidance from Influenza.
    J Infect Dis. 2022 Nov 25:jiac454. doi: 10.1093.
    PubMed         Abstract available


    J Virol

  26. WANG X, Kerkmann L, Hetzel M, Windmann S, et al
    Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
    J Virol. 2022 Nov 7:e0113322. doi: 10.1128/jvi.01133.
    PubMed         Abstract available

  27. LI J, Xue L, Wang J, Meng A, et al
    Activation of the Chemokine Receptor CCR1 and Preferential Recruitment of Galphai Suppress RSV Replication: Implications for Developing Novel Respiratory Syncytial Virus Treatment Strategies.
    J Virol. 2022;96:e0130922.
    PubMed         Abstract available

  28. STEPHENS LM, Ross KA, McLellan JS, Narasimhan B, et al
    Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model.
    J Virol. 2022;96:e0150222.
    PubMed         Abstract available

  29. SACCO MT, Bland KM, Horner SM
    WTAP Targets the METTL3 m(6)A-Methyltransferase Complex to Cytoplasmic Hepatitis C Virus RNA to Regulate Infection.
    J Virol. 2022 Oct 31:e0099722. doi: 10.1128/jvi.00997.
    PubMed         Abstract available


    JAMA

  30. SLOMSKI A
    Intranasal COVID-19 Vaccine Disappointing in First-in-Human Trial.
    JAMA. 2022;328:2003.
    PubMed        


    Lancet

  31. JAFFE S
    US CDC begins agency-wide changes after pandemic failures.
    Lancet. 2022;400:1754-1755.
    PubMed        

  32. HORTON R
    Offline: COVID-19-the lessons that science forgot.
    Lancet. 2022;400:1753.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  33. MINTA AA, Ferrari M, Antoni S, Portnoy A, et al
    Progress Toward Regional Measles Elimination - Worldwide, 2000-2021.
    MMWR Morb Mortal Wkly Rep. 2022;71:1489-1495.
    PubMed         Abstract available

  34. HOPKINS DR, Weiss AJ, Yerian S, Sapp SGH, et al
    Progress Toward Global Eradication of Dracunculiasis - Worldwide, January 2021-June 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1496-1502.
    PubMed         Abstract available

  35. CZEISLER ME, Lane RI, Orellana RC, Lundeen K, et al
    Perception of Local COVID-19 Transmission and Use of Preventive Behaviors Among Adults with Recent SARS-CoV-2 Infection - Illinois and Michigan, June 1-July 31, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1471-1478.
    PubMed         Abstract available

  36. SANTIBANEZ TA, Zhou T, Black CL, Vogt TM, et al
    Sociodemographic Variation in Early Uptake of COVID-19 Vaccine and Parental Intent and Attitudes Toward Vaccination of Children Aged 6 Months-4 Years - United States, July 1-29, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1479-1484.
    PubMed         Abstract available


    N Engl J Med

  37. ABERG M, Smed-Sorensen A, Thalin C
    Mucosal IgA against SARS-CoV-2 Omicron Infection. Reply.
    N Engl J Med. 2022;387:e55.
    PubMed        

  38. ZUO F, Marcotte H, Hammarstrom L, Pan-Hammarstrom Q, et al
    Mucosal IgA against SARS-CoV-2 Omicron Infection.
    N Engl J Med. 2022;387:e55.
    PubMed        

  39. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Making Choices about Covid-19.
    N Engl J Med. 2022;387:e64.
    PubMed        

  40. RAIFMAN J, Green T
    Universal Masking Policies in Schools and Mitigating the Inequitable Costs of Covid-19.
    N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMe2213556.
    PubMed        

  41. COWGER TL, Murray EJ, Clarke J, Bassett MT, et al
    Lifting Universal Masking in Schools - Covid-19 Incidence among Students and Staff.
    N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMoa2211029.
    PubMed         Abstract available

  42. CHESKES S, Verbeek PR, Drennan IR, McLeod SL, et al
    Defibrillation Strategies for Refractory Ventricular Fibrillation.
    N Engl J Med. 2022 Nov 6. doi: 10.1056/NEJMoa2207304.
    PubMed         Abstract available


    Pediatrics

  43. SAHA S, Pal P, Mukherjee D
    Neonatal MIS-C: Managing the Cytokine Storm.
    Pediatrics. 2021;148.
    PubMed         Abstract available

  44. PATEL KM, Malik AA, Lee A, Klotz M, et al
    COVID-19 Vaccine Uptake Among US Child Care Providers.
    Pediatrics. 2021;148.
    PubMed         Abstract available


    PLoS Med

  45. NIELSEN KF, Moustsen-Helms IR, Schelde AB, Gram MA, et al
    Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    PLoS Med. 2022;19:e1004037.
    PubMed         Abstract available

  46. BABOUEE FLURY B, Gusewell S, Egger T, Leal O, et al
    Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    PLoS Med. 2022;19:e1004125.
    PubMed         Abstract available


    PLoS One

  47. FAVIER V, Lescroart M, Pequignot B, Grimmer L, et al
    Measurement of airborne particle emission during surgical and percutaneous dilatational tracheostomy COVID-19 adapted procedures in a swine model: Experimental report and review of literature.
    PLoS One. 2022;17:e0278089.
    PubMed         Abstract available

  48. CALVET L, Thouy F, Mascle O, Sapin AF, et al
    Hypercoagulability in critically ill patients with COVID 19, an observational prospective study.
    PLoS One. 2022;17:e0277544.
    PubMed         Abstract available

  49. FOLLONIER C, Tessitore E, Handgraaf S, Carballo D, et al
    Cardiovascular therapy use, modification, and in-hospital death in patients with COVID-19: A cohort study.
    PLoS One. 2022;17:e0277653.
    PubMed         Abstract available

  50. KWAN BM, Sobczak C, Gorman C, Roberts S, et al
    "All of the things to everyone everywhere": A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19.
    PLoS One. 2022;17:e0274043.
    PubMed         Abstract available

  51. MIHAJLOVSKI K, Buttner MP, Cruz P, Labus B, et al
    SARS-CoV-2 surveillance with environmental surface sampling in public areas.
    PLoS One. 2022;17:e0278061.
    PubMed         Abstract available

  52. GALDIKIENE L, Jaraite J, Kajackaite A
    Trust and vaccination intentions: Evidence from Lithuania during the COVID-19 pandemic.
    PLoS One. 2022;17:e0278060.
    PubMed         Abstract available

  53. PETROF O, Fajgenblat M, Neyens T, Molenberghs G, et al
    The doubling effect of COVID-19 cases on key health indicators.
    PLoS One. 2022;17:e0275523.
    PubMed         Abstract available

  54. KRAUT RE, Li H, Zhu H
    Mental health during the COVID-19 pandemic: Impacts of disease, social isolation, and financial stressors.
    PLoS One. 2022;17:e0277562.
    PubMed         Abstract available

  55. TISLER A, Stirrup O, Pisarev H, Kalda R, et al
    Post-acute sequelae of COVID-19 among hospitalized patients in Estonia: Nationwide matched cohort study.
    PLoS One. 2022;17:e0278057.
    PubMed         Abstract available

  56. WRIGHT DB, Wolff SM, Jaspal R, Barnett J, et al
    The choice of response alternatives in COVID-19 social science surveys.
    PLoS One. 2022;17:e0263552.
    PubMed         Abstract available

  57. SAILE K, Munz R, Huttl-Maack V
    How providing public COVID-19 mitigation instructions in a foreign language can increase people's sense of control.
    PLoS One. 2022;17:e0277366.
    PubMed         Abstract available

  58. OZDEMIR C, Reiter C, Yildiz D, Goujon A, et al
    Projections of adult skills and the effect of COVID-19.
    PLoS One. 2022;17:e0277113.
    PubMed         Abstract available

  59. JEFFERSON C, Watson E, Certa JM, Gordon KS, et al
    Differences in COVID-19 testing and adverse outcomes by race, ethnicity, sex, and health system setting in a large diverse US cohort.
    PLoS One. 2022;17:e0276742.
    PubMed         Abstract available

  60. PANTELIC M, Ziauddeen N, Boyes M, O'Hara ME, et al
    Long Covid stigma: Estimating burden and validating scale in a UK-based sample.
    PLoS One. 2022;17:e0277317.
    PubMed         Abstract available

  61. JOSHI DR, Adhikari KP, Khanal B, Khadka J, et al
    Behavioral, cognitive, emotional and social engagement in mathematics learning during COVID-19 pandemic.
    PLoS One. 2022;17:e0278052.
    PubMed         Abstract available

  62. BOURI E, Kristoufek L, Azoury N
    Bitcoin and S&P500: Co-movements of high-order moments in the time-frequency domain.
    PLoS One. 2022;17:e0277924.
    PubMed         Abstract available

  63. GITOMER SA, Tholen K, Pickett K, Mistry RD, et al
    Olfactory testing as COVID-19 screening in school children; A prospective cross-sectional study.
    PLoS One. 2022;17:e0277882.
    PubMed         Abstract available

  64. RASHID F, Erfan Uddin RAM, Mehedi HMH, Dhar S, et al
    Burnout syndrome among frontline doctors of secondary and tertiary care hospitals of Bangladesh during COVID-19 pandemic.
    PLoS One. 2022;17:e0277875.
    PubMed         Abstract available

  65. ASHAGRE W, Atnafu A, Wassie L, Tschopp R, et al
    Evaluation of the diagnostic performance of PanbioTM Abbott SARS-CoV-2 rapid antigen test for the detection of COVID-19 from suspects attending ALERT center.
    PLoS One. 2022;17:e0277779.
    PubMed         Abstract available

  66. KOMATSU H, Kubota H, Tanaka N, Ohashi H, et al
    Searching for the universality of nudging: A cross-cultural comparison of the information effects of reminding people about familial support.
    PLoS One. 2022;17:e0277969.
    PubMed         Abstract available

  67. PINHO RDNL, Costa TF, Silva NM, Barros-Areal AF, et al
    High prevalence of burnout syndrome among medical and nonmedical residents during the COVID-19 pandemic.
    PLoS One. 2022;17:e0267530.
    PubMed         Abstract available

  68. BJORKHEIM S, Saetrevik B
    Manipulating risk of infection and appeal to public benefit increase compliance with infection control measures in a hypothetical pandemic scenario.
    PLoS One. 2022;17:e0274024.
    PubMed         Abstract available

  69. LEE HJ, Lee HK, Kim YR
    The impact of caregivers on nosocomial transmission during a COVID-19 outbreak in a community-based hospital in South Korea.
    PLoS One. 2022;17:e0277816.
    PubMed         Abstract available

  70. FRANCIS-TAN A, Wang X
    Spatiotemporal patterns of lung disease in China before 2019: A brief analysis of two nationally representative surveys.
    PLoS One. 2022;17:e0278031.
    PubMed         Abstract available

  71. BARRAGAN D, Howard JJ, Rabbitt LR, Sirotin YB, et al
    COVID-19 masks increase the influence of face recognition algorithm decisions on human decisions in unfamiliar face matching.
    PLoS One. 2022;17:e0277625.
    PubMed         Abstract available

  72. HUYNH PK, Setty AR, Tran QM, Yadav OP, et al
    A domain-knowledge modeling of hospital-acquired infection risk in Healthcare personnel from retrospective observational data: A case study for COVID-19.
    PLoS One. 2022;17:e0272919.
    PubMed         Abstract available

  73. FLEERACKERS A, Moorhead LL, Maggio LA, Fagan K, et al
    Science in motion: A qualitative analysis of journalists' use and perception of preprints.
    PLoS One. 2022;17:e0277769.
    PubMed         Abstract available

  74. BOLDEANU FT, Clemente-Almendros JA, Segui-Amortegui LA, Duguleana C, et al
    A comparative study on renewable and traditional electricity: The influence of the European Union framework and the impact of COVID-19.
    PLoS One. 2022;17:e0277088.
    PubMed         Abstract available

  75. SARRIGEORGIOU I, Moschandreou D, Dimitriadis A, Tsinti G, et al
    Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers.
    PLoS One. 2022;17:e0277827.
    PubMed         Abstract available

  76. BHAVANAM S, Lee B, Qiu Y, Zelyas N, et al
    Evaluation of compressed sodium chloride on the inactivation of SARS-CoV-2 and surrogates.
    PLoS One. 2022;17:e0277881.
    PubMed         Abstract available

  77. CABELLO-UBEDA A, de Quiros JCLB, Martin Carbonero L, Sanz J, et al
    48-Week effectiveness and tolerability of dolutegravir (DTG) + lamivudine (3TC) in antiretroviral-naive adults living with HIV: A multicenter real-life cohort.
    PLoS One. 2022;17:e0277606.
    PubMed         Abstract available

  78. DONAGHY B, Walker SC, Moore DJ
    Social distancing with chronic pain during COVID-19: A cross-sectional correlational analysis.
    PLoS One. 2022;17:e0275680.
    PubMed         Abstract available

  79. ALOMARI F, A Hamid AB
    Strategies to improve patient loyalty and medication adherence in Syrian healthcare setting: The mediating role of patient satisfaction.
    PLoS One. 2022;17:e0272057.
    PubMed         Abstract available

  80. OLUSANYA OA, White B, Malik F, Hester KA, et al
    Healthcare professionals' perceptions and recommendations regarding adolescent vaccinations in Georgia and Tennessee during the COVID-19 pandemic: A qualitative research.
    PLoS One. 2022;17:e0277748.
    PubMed         Abstract available

  81. MHANNA M, El Zouki CJ, Chahine A, Obeid S, et al
    Dissociative experiences among Lebanese university students: Association with mental health issues, the economic crisis, the COVID-19 pandemic, and the Beirut port explosion.
    PLoS One. 2022;17:e0277883.
    PubMed         Abstract available

  82. REZAPOUR M, Elmshaeuser SK
    Artificial intelligence-based analytics for impacts of COVID-19 and online learning on college students' mental health.
    PLoS One. 2022;17:e0276767.
    PubMed         Abstract available

  83. DARWEESH O, Khatab N, Kheder R, Mohammed T, et al
    Assessment of COVID-19 vaccination among healthcare workers in Iraq; adverse effects and hesitancy.
    PLoS One. 2022;17:e0274526.
    PubMed         Abstract available

  84. SAWAN HM, Al Omari SM, Al Bahar F, Karasneh R, et al
    Assessment of Jordanian health care professionals' perception towards new COVID-19 variants of concern.
    PLoS One. 2022;17:e0265797.
    PubMed         Abstract available

  85. BEK J, Leventhal D, Groves M, Growcott C, et al
    Moving online: Experiences and potential benefits of digital dance for older adults and people with Parkinson's disease.
    PLoS One. 2022;17:e0277645.
    PubMed         Abstract available

  86. OLSON A, Rajgopal S, Bai G
    Comparison of resident COVID-19 mortality between unionized and nonunionized private nursing homes.
    PLoS One. 2022;17:e0276301.
    PubMed         Abstract available

  87. LATHAN R, Sidapra M, Yiasemidou M, Long J, et al
    The diagnostic test accuracy of telemedicine for detection of surgical site infection: A systematic review protocol.
    PLoS One. 2022;17:e0263549.
    PubMed         Abstract available

  88. HOY C, Wood T, Moscoe E
    Addressing vaccine hesitancy in developing countries: Survey and experimental evidence.
    PLoS One. 2022;17:e0277493.
    PubMed         Abstract available

  89. GALLARDO-RINCON H, Gascon JL, Martinez-Juarez LA, Montoya A, et al
    MIDO COVID: A digital public health strategy designed to tackle chronic disease and the COVID-19 pandemic in Mexico.
    PLoS One. 2022;17:e0277014.
    PubMed         Abstract available

  90. STRACQUALURSI L, Agati P
    Covid-19 vaccines in Italian public opinion: Identifying key issues using Twitter and Natural Language Processing.
    PLoS One. 2022;17:e0277394.
    PubMed         Abstract available

  91. LIM SY, Choi SY
    Impact of liquidity spillovers among industrial sectors on stock markets during crisis periods: Evidence from the S&P 500 index.
    PLoS One. 2022;17:e0277261.
    PubMed         Abstract available

  92. MELE-CASAS M, Launes C, de Sevilla MF, Hernandez-Garcia M, et al
    Low transmission of SARS-CoV-2 derived from children in family clusters: An observational study of family households in the Barcelona Metropolitan Area, Spain.
    PLoS One. 2022;17:e0277754.
    PubMed         Abstract available

  93. GANEM F, Bordas A, Folch C, Alonso L, et al
    The COVID-19 Sentinel Schools Network of Catalonia (CSSNC) project: Associated factors to prevalence and incidence of SARS-CoV-2 infection in educational settings during the 2020-2021 academic year.
    PLoS One. 2022;17:e0277764.
    PubMed         Abstract available

  94. WONG CK, Sia LC, Ooi NZM, Chan WY, et al
    Severe COVID-19 with persistent respiratory failure-A retrospective cohort study in a tertiary centre in Malaysia.
    PLoS One. 2022;17:e0276848.
    PubMed         Abstract available

  95. ACCIAI C, Holding BC, W Schneider J, W Nielsen M, et al
    Institution and gender-related differences in publication speed before and during COVID-19.
    PLoS One. 2022;17:e0277011.
    PubMed         Abstract available

  96. CHIDZONGA MM, Haruzivishe C, Chikwasha V, Rukweza J, et al
    Health professions faculty's perceptions of online teaching and learning during the COVID-19 pandemic.
    PLoS One. 2022;17:e0276170.
    PubMed         Abstract available

  97. YAZJI B, Voduc N, Mulpuru S, Cowan J, et al
    Pulmonary sequelae of SARS-CoV-2 infection and factors associated with persistent abnormal lung function at six months after infection: Prospective cohort study.
    PLoS One. 2022;17:e0277624.
    PubMed         Abstract available

  98. REICHERT F, Stier O, Hartmann A, Ruscher C, et al
    Analysis of two choir outbreaks acting in concert to characterize long- range transmission risks through SARS-CoV-2, Berlin, Germany, 2020.
    PLoS One. 2022;17:e0277699.
    PubMed         Abstract available

  99. LEE TK, Benish-Weisman M, Vos SR, Garcia MF, et al
    Psychological distress, employment, and family functioning during the COVID-19 outbreak among recent immigrant families in Israel: Moderating roles of COVID-19 prevalence.
    PLoS One. 2022;17:e0277757.
    PubMed         Abstract available

  100. KODCHAKORN K, Kongtawelert P
    Molecular dynamics study on the strengthening behavior of Delta and Omicron SARS-CoV-2 spike RBD improved receptor-binding affinity.
    PLoS One. 2022;17:e0277745.
    PubMed         Abstract available

  101. PONGOU R, Ahinkorah BO, Maltais S, Mabeu MC, et al
    Psychological distress during the COVID-19 pandemic in Canada.
    PLoS One. 2022;17:e0277238.
    PubMed         Abstract available

  102. BRAMANTE CT, Johnson SG, Garcia V, Evans MD, et al
    Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study.
    PLoS One. 2022;17:e0271574.
    PubMed         Abstract available

  103. COUSINS MM, Van Til M, Steppe E, Ng S, et al
    Age, race, insurance type, and digital divide index are associated with video visit completion for patients seen for oncologic care in a large hospital system during the COVID-19 pandemic.
    PLoS One. 2022;17:e0277617.
    PubMed         Abstract available

  104. ABE T, Yoshida N, Shimada T, Nakashima M, et al
    Respiratory frequency-tunable dynamic imaging for lung function: New exam method using chest X-ray cine imaging considering various respiratory diseases.
    PLoS One. 2022;17:e0276859.
    PubMed         Abstract available

  105. FERNANDEZ VELASCO P, Gurchani U, Perroy B, Pelletreau-Duris T, et al
    Development and validation of a quantitative instrument for measuring temporal and social disorientation in the Covid-19 crisis.
    PLoS One. 2022;17:e0264604.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  106. DU Z, Wang L, Shan S, Lam D, et al
    Pandemic fatigue impedes mitigation of COVID-19 in Hong Kong.
    Proc Natl Acad Sci U S A. 2022;119:e2213313119.
    PubMed         Abstract available

  107. JORGENSEN F, Bor A, Rasmussen MS, Lindholt MF, et al
    Pandemic fatigue fueled political discontent during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2022;119:e2201266119.
    PubMed         Abstract available

  108. KAO KS, Gupta A, Zong G, Li C, et al
    Synthetic nanobodies as tools to distinguish IgG Fc glycoforms.
    Proc Natl Acad Sci U S A. 2022;119:e2212658119.
    PubMed         Abstract available


    Vaccine

  109. NIQUEUX E, Flodrops M, Allee C, Lebras MO, et al
    Evaluation of three hemagglutinin-based vaccines for the experimental control of a panzootic clade 2.3.4.4b A(H5N8) high pathogenicity avian influenza virus in mule ducks.
    Vaccine. 2022 Nov 18:S0264-410X(22)01398-6. doi: 10.1016/j.vaccine.2022.
    PubMed         Abstract available

  110. CAETANO C, Morgado ML, Patricio P, Leite A, et al
    Measuring the impact of COVID-19 vaccination and immunity waning: A modelling study for Portugal.
    Vaccine. 2022;40:7115-7121.
    PubMed         Abstract available

  111. KAUFMANN J, DeVoe JE, Angier H, Moreno L, et al
    Association of parent influenza vaccination and early childhood vaccinations using linked electronic health record data.
    Vaccine. 2022;40:7097-7107.
    PubMed         Abstract available

  112. HASSAN YAM, Daud Ali M, Al-Eid RR, Al-Ghuraya FA, et al
    A retrospective evaluation of side-effects associated with the booster dose of Pfizer-BioNTech/BNT162b2 COVID-19 vaccine among females in Eastern Province, Saudi Arabia.
    Vaccine. 2022;40:7087-7096.
    PubMed         Abstract available

  113. FRANCO C, Herazo-Padilla N, Castaneda JA
    A queueing Network approach for capacity planning and patient Scheduling: A case study for the COVID-19 vaccination process in Colombia.
    Vaccine. 2022;40:7073-7086.
    PubMed         Abstract available

  114. CRUZ MC, Nascimento-Carvalho CM
    The early evolution of COVID-19 incidence and mortality among people aged under 80 years or 80 years and above after COVID-19 vaccine implementation in the state of Bahia, Brazil.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01335.
    PubMed         Abstract available

  115. LEUNG J, Gray EB, Anderson TC, Sharkey SM, et al
    Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States.
    Vaccine. 2022 Nov 5. pii: S0264-410X(22)01328.
    PubMed         Abstract available

  116. SCHIFF J, Schmidt AR, Pham PK, Perez JB, et al
    Parental attitudes in the pediatric emergency department about the COVID-19 vaccine.
    Vaccine. 2022 Oct 26. pii: S0264-410X(22)01309.
    PubMed         Abstract available

  117. MALTEZOU HC, Ledda C, Gagneux-Brunon A, Botelho-Nevers E, et al
    Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants.
    Vaccine. 2022 Oct 26. pii: S0264-410X(22)01313.
    PubMed        

  118. LIMAYE RJ, Paul A, Gur-Arie R, Zavala E, et al
    A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01331.
    PubMed         Abstract available

  119. CAPURRO G, Maier R, Tustin J, Jardine CG, et al
    "They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01338.
    PubMed         Abstract available

  120. SIANI A, Tranter A
    Is vaccine confidence an unexpected victim of the COVID-19 pandemic?
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01337.
    PubMed         Abstract available

  121. MARIE REINHART A, Tian Y, Lilly AE
    The role of trust in COVID-19 vaccine hesitancy and acceptance among Black and White Americans.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01330.
    PubMed         Abstract available

  122. ARRIETA A, Garcia-Prado A, Sarmiento JP, Paz Castro C, et al
    Identifying early adopters of COVID-19 vaccines in Latin America.
    Vaccine. 2022 Oct 21. pii: S0264-410X(22)01294.
    PubMed         Abstract available

  123. HODGSON D, Koltai M, Krauer F, Flasche S, et al
    Optimal Respiratory Syncytial Virus intervention programmes using Nirsevimab in England and Wales.
    Vaccine. 2022;40:7151-7157.
    PubMed         Abstract available

  124. ZHOU W, Tang B, Bai Y, Shao Y, et al
    The resurgence risk of COVID-19 in China in the presence of immunity waning and ADE: A mathematical modelling study.
    Vaccine. 2022;40:7141-7150.
    PubMed         Abstract available

  125. THULUVA S, Paradkar V, Gunneri S, Yerroju V, et al
    Safety, tolerability and immunogenicity of Biological E's CORBEVAX vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01308.
    PubMed         Abstract available

  126. HOSHI SL, Shono A, Seposo X, Okubo R, et al
    Cost-effectiveness analyses of 15- and 20-valent pneumococcal conjugate vaccines for Japanese elderly.
    Vaccine. 2022 Oct 20. pii: S0264-410X(22)01259.
    PubMed         Abstract available

  127. RHODES S, Smith N, Evans T, White R, et al
    Identifying COVID-19 optimal vaccine dose using mathematical immunostimulation/immunodynamic modelling.
    Vaccine. 2022 Oct 17. pii: S0264-410X(22)01260.
    PubMed         Abstract available

  128. NTZIORA F, Georgia Kostaki E, Karapanou A, Mylona M, et al
    Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers.
    Vaccine. 2022 Sep 19. pii: S0264-410X(22)01150.
    PubMed         Abstract available


    Virology

  129. SANTOS LA, Almeida F, Giria M, Trigueiro-Louro J, et al
    Adaptive evolution of PB1 from influenza A(H1N1)pdm09 virus towards an enhanced fitness.
    Virology. 2022;578:1-6.
    PubMed         Abstract available


    Virus Res

  130. RUANGRUNG K, Chakritbudsabong W, Thongon S, Rungarunlert S, et al
    Analysis of Influenza A virus infection in human induced pluripotent stem cells (hiPSCs) and their derivatives.
    Virus Res. 2022 Nov 19:199009. doi: 10.1016/j.virusres.2022.199009.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: